Specific Viral Targeting of Hematopoietic Stem Cells via Engineering of Viral Tropism
Exclusively Licensed
Invention type: Technology
/
Case number: #22988JQ
Researchers
Michael Birnbaum
/
Cassandra Burnett
/
Kole Roybal
/
Stephanie Gaglione
/
Connor Dobson
Departments: Department of Biological Engineering, David H Koch Institute for Integrative Cancer Res
Technology Areas: Biotechnology: DNA & RNA Editing, Synthetic Biology / Drug Delivery: Vectors & Virus like Particles / Therapeutics: Cell Based Therapy, Nucleic Acids
Impact Areas: Healthy Living
-
viral targeting of hematopoietic stem cells
Singapore | Pending -
viral targeting of hematopoietic stem cells
United States of America | Published application -
viral targeting of hematopoietic stem cells
Hong Kong | Published application -
viral targeting of hematopoietic stem cells
Australia | Pending -
viral targeting of hematopoietic stem cells
Brazil | Pending -
viral targeting of hematopoietic stem cells
Canada | Published application -
viral targeting of hematopoietic stem cells
China | Published application -
viral targeting of hematopoietic stem cells
Eurasian Patent Organization | Published application -
viral targeting of hematopoietic stem cells
European Patent Convention | Published application -
viral targeting of hematopoietic stem cells
Israel | Pending -
viral targeting of hematopoietic stem cells
India | Pending -
viral targeting of hematopoietic stem cells
Japan | Published application -
viral targeting of hematopoietic stem cells
Korea (south) | Published application -
viral targeting of hematopoietic stem cells
Mexico | Published application -
viral targeting of hematopoietic stem cells
New Zealand | Pending
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.